UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060131
Receipt number R000068084
Scientific Title Proactive Use of Cognitive Behavioral Therapy: Can Preoperative Psychological Intervention Reduce Postoperative Pain After Spine Surgery?
Date of disclosure of the study information 2025/12/22
Last modified on 2025/12/19 12:04:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Proactive Use of Cognitive Behavioral Therapy: Can Preoperative Psychological Intervention Reduce Postoperative Pain After Spine Surgery?

Acronym

Proactive Use of Cognitive Behavioral Therapy: Can Preoperative Psychological Intervention Reduce Postoperative Pain After Spine Surgery?

Scientific Title

Proactive Use of Cognitive Behavioral Therapy: Can Preoperative Psychological Intervention Reduce Postoperative Pain After Spine Surgery?

Scientific Title:Acronym

Proactive Use of Cognitive Behavioral Therapy: Can Preoperative Psychological Intervention Reduce Postoperative Pain After Spine Surgery?

Region

Japan


Condition

Condition

Spinal stenosis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to compare treatment outcomes between patients who receive cognitive behavioral therapy (CBT) before spinal surgery and those who do not. This study aims to investigate whether the application of CBT from the preoperative period improves surgical outcomes and to examine the significance of preoperative CBT. In addition, patient characteristics for whom CBT is effective will be explored. If preoperative CBT is shown to be effective, it is expected that implementing psychological interventions from the preoperative stage may help prevent postoperative pain and its chronification in the future.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Japanese Orthopaedic Association back pain evaluation questionnaire (JOABPEQ)

Key secondary outcomes

Pain Catastrophizing Scale (PCS)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Cognitive behavioral therapy (CBT) will be conducted once preoperatively and twice during postoperative hospitalization, with each session lasting approximately 40-50 minutes. Participants will complete questionnaires assessing outcome measures (approximately 10 minutes) at the following time points: preoperatively (Visit 1), 3 months postoperatively (Visit 2), 6 months postoperatively (Visit 3), 1 year postoperatively (Visit 4), and 2 years postoperatively (Visit 5). Surgical outcomes will be evaluated based on these assessments.

Interventions/Control_2

Participants in the control group who do not receive CBT will be asked to complete questionnaires assessing outcome measures (approximately 10 minutes) at the following time points: preoperatively (Visit 1), 3 months postoperatively (Visit 2), 6 months postoperatively (Visit 3), 1 year postoperatively (Visit 4), and 2 years postoperatively (Visit 5). Surgical outcomes will be evaluated based on these assessments.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who will undergo spinal surgery at Toyama University Hospital.

Patients whose pain can be evaluated and whose preoperative Visual Analog Scale (VAS) score is greater than 5.

Patients who are judged to be eligible for this study by the principal investigator (or sub-investigator) based on medical history, physical examination, and clinical assessment.

Patients who have provided written informed consent and who are judged by the principal investigator (or sub-investigator) to be able to comply with the study requirements, undergo the examinations, tests, and surgery necessary for the conduct of this study, and report symptoms during the study period.

Key exclusion criteria

Patients who did not provide informed consent to participate in the study.

Patients who have difficulty with verbal communication.

Patients with a history of cognitive impairment or dementia.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Yoshiharu
Middle name
Last name Kawaguchi

Organization

University of Toyama

Division name

Department of Orthopaedic Surgery

Zip code

930-0194

Address

2630 Sugitani,Toyamashi,Toyama,Japan

TEL

076-434-7353

Email

zenji@med.u-toyama.ac.jp


Public contact

Name of contact person

1st name Yuko
Middle name
Last name Mizukami

Organization

University of Toyama

Division name

Department of Orthopaedic Surgery

Zip code

930-0194

Address

2630 Sugitani,Toyamashi,Toyama,Japan

TEL

076-434-7353

Homepage URL


Email

yk1022@med.u-toyama.ac.jp


Sponsor or person

Institute

University of Toyama

Institute

Department

Personal name



Funding Source

Organization

University of Toyama

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Toyama, Research Ethics Office for Human Subjects

Address

2630 Sugitani,Toyamashi,Toyama,Japan

Tel

076-415-8857

Email

kenrinri@adm.u-toyama.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 12 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 10 Month 16 Day

Date of IRB


Anticipated trial start date

2026 Year 01 Month 05 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 12 Month 19 Day

Last modified on

2025 Year 12 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068084